|
N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-4-(1,3-oxazol-5-yl)benzamide |
|
Yersinia |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Garrity-Ryan LK, et al. 2010. Infect Immun |
|
(E)-3-(4-Acetyl-phenyl)-N-[4-(1-hydroxy-6-nitro-1H-benzoimidazol-2-yl)-phenyl]-acrylamide |
Depiction based on curated SMILES
N
+
N
O
_
O
N
HO
H
3
C
N
H
O
O
|
Pseudomonas |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Marsden AE, et al. 2016. Antimicrob Agents Chemother |
|
(E)-3-(4-acetylphenyl)-N-(4-(6-cyano-1-hydroxy-1H-benzo[d]imidazol-2-yl)phenyl)acrylamide |
Depiction based on curated SMILES
HO
N
N
N
H
3
C
N
H
O
O
|
Pseudomonas |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Marsden AE, et al. 2016. Antimicrob Agents Chemother |
|
(E)-3-(4-fluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide |
Depiction based on curated SMILES
HO
N
_
O
O
+
N
N
O
N
H
F
|
Pseudomonas Yersinia Yersinia |
TTSS (Type III secretion system) TTSS (Type III secretion system) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vitro) Preclinical (in vivo) |
Marsden AE, et al. 2016. Antimicrob Agents Chemother Kim OK, et al. 2009. J Med Chem Garrity-Ryan LK, et al. 2010. Infect Immun |
|
4-fluoro-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]benzamide |
Depiction based on curated SMILES
O
F
OH
N
_
O
O
+
N
N
N
H
|
Pseudomonas |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Marsden AE, et al. 2016. Antimicrob Agents Chemother |
|
N-[2-[4-(benzimidazol-1-yl)anilino]-2-oxoethyl]-3-chloro-1-benzothiophene-2-carboxamide |
Depiction based on curated SMILES
N
H
N
N
O
S
Cl
O
N
H
|
Salmonella Yersinia |
TTSS (SPI-1 encode) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vivo) |
Boonyom R, et al. 2022. J Genet Eng Biotechnol Swietnicki W, et al. 2011. PLoS One |
|
(E)-3-(4-fluorophenyl)-N-[4-(1-hydroxy-5-methyl-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide |
Depiction based on curated SMILES
O
N
H
3
C
+
N
_
O
N
OH
H
F
O
N
|
Yersinia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Kim OK, et al. 2009. J Med Chem |
|
(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methoxyphenyl)prop-2-enamide |
Depiction based on curated SMILES
_
O
O
+
N
OH
N
N
CH
3
N
H
O
O
|
Yersinia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Kim OK, et al. 2009. J Med Chem |
|
| | |
| | |
| | |
| | |
| | |